Ian Ford

68.3k total citations · 19 hit papers
357 papers, 34.1k citations indexed

About

Ian Ford is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ian Ford has authored 357 papers receiving a total of 34.1k indexed citations (citations by other indexed papers that have themselves been cited), including 160 papers in Cardiology and Cardiovascular Medicine, 104 papers in Surgery and 55 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ian Ford's work include Lipoproteins and Cardiovascular Health (61 papers), Cardiac Imaging and Diagnostics (47 papers) and Blood Pressure and Hypertension Studies (37 papers). Ian Ford is often cited by papers focused on Lipoproteins and Cardiovascular Health (61 papers), Cardiac Imaging and Diagnostics (47 papers) and Blood Pressure and Hypertension Studies (37 papers). Ian Ford collaborates with scholars based in United Kingdom, Netherlands and United States. Ian Ford's co-authors include James Shepherd, Stuart M. Cobbe, Peter W. Macfarlane, Christopher J. Packard, Christopher Isles, A R Lorimer, James H. McKillop, Chris J. Packard, Naveed Sattar and Allan Gaw and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Ian Ford

345 papers receiving 32.7k citations

Hit Papers

Prevention of Coronary Heart Disease with Pravastatin in ... 1989 2026 2001 2013 1995 2002 2003 1989 1998 1000 2.0k 3.0k 4.0k 5.0k

Peers

Ian Ford
Comparison fields: 5 of 203
  • Cardiology and Cardiovascular Medicine 12.0k
  • Surgery 11.6k
  • Endocrinology, Diabetes and Metabolism 6.8k
  • Epidemiology 5.3k
  • Economics and Econometrics 3.5k
Replace Patrick E. McBride with:
Patrick E. McBride United States
Michael Pencina United States
Richard C. Pasternak United States
Curt D. Furberg United States
Salim S. Virani United States
Nancy R. Cook United States
Bruce M. Psaty United States
Robert H. Eckel United States
Neil J. Stone United States
David C. Goff United States
Patrick E. McBride United States View profile →
Citations per field, relative to Ian Ford
Ian Ford · 1×
Citations per year, relative to Ian Ford
Ian Ford · 1×

Countries citing papers authored by Ian Ford

Since Specialization
Citations

This map shows the geographic impact of Ian Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Ford more than expected).

Fields of papers citing papers by Ian Ford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Ford. The network helps show where Ian Ford may publish in the future.

Co-authorship network of co-authors of Ian Ford

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Ford. A scholar is included among the top collaborators of Ian Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Ford. Ian Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 8
2 6
3 14
4 4
5 16
6
Nuclear magnetic resonance‐based metabolomics identifies phenylalanine as a novel predictor of incident heart failure hospitalisation:results from PROSPER and FINRISK 1997
51
7 118
8 169
9 10
10
Metformin in type 1 diabetes: methods and baseline characteristics of the REMOVAL trial
1
11
The REMOVAL trial (Reducing with Metformin Vascular Adverse Lesions) in Type 1 diabetes: methods and baseline characteristics
1
12 82
13 111
14 7
15 56
16 17
17 310
18 50
19 42
20
Statin prescribing: is the reality meeting the expectations of primary care?
2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026